Abstract:Dear Editor, Gout is a paradoxical disease in that arthritis attacks are only intermittent, whereas the arthritis-causing uric acid is persistently in excess in the form of tophi. For each patient, the ultimate therapeutic ideal should be to completely eliminate all tophi. So far, clinicians have relied on physical examination and plain radiographs to assess the locations and sizes of gouty tophi.1 Published reports suggest that dual energy computed tomography (DECT), magnetic resonance imaging (MRI) and 2-fluoro-deoxy-d-glucose (FDG) positron emission tomography (PET) each offer a different perspective of gouty tophi.2 DECT is capable of discriminating urate from non-urate compounds.3, 4 MRI is capable of delimiting the sizes of the tophi and their relationship to adjacent tissues.5 PET is capable of assessing the degree of inflammation.6 Because no study had used all four techniques concomitantly, no guidelines are available concerning their applications. In this paper, we used these four techniques to examine the same feet and knees of a patient with chronic tophaceous in gout. The results indicate two huge tophi that would have eluded detection and assessment by physical examination and plain radiographs alone in this patient. The patient is a 62-year-old man with intermittent gouty arthritis attacks of the joints of the lower extremities for 20 years. Physical examination showed tophi-like swelling at the left big toe, and minor joint swelling of both knees. Serum uric acid was 8.6 mg/L. The diagnosis of gout was confirmed by crystal examination. Plain radiographs and 3.0T MRI followed conventional methods. DECT and FDG-PET utilized the Siemens Somatom Definition Syngo 2010A and the Siemens Biograph 16 (Knoxville, TN, USA), respectively. Unsuspected from physical examination and plain radiographs, DECT shows a large urate tophus at the supra-patella region of the left knee, the length exceeding that of the patella (Fig. 1a), and having intense FDG signal in PET (Fig. 1c). X-ray shows only a small erosion to which the tophus is attached (Fig. 2c). The conventional MRI view shows only the inferior part of the tophus (Fig. 2a). The T2 sequences show that it is extra-articular (not shown). Equally surprising, although the posterior view of the DECT shows only scattered urate signals, MRI and PET reveal that they are part of another massive tophus (Figs 1b and 2b). These features are not seen in the corresponding images of the right knee (not shown). For the tophus in the first big toe, this is visualized as soft tissue swelling and bone erosion on X-ray (Fig. 3a, left foot panel), and urate as well as fibrous mass on DECT (Fig. 3b left foot panel), and a heterogeneous mass on MRI (Fig. 3c). PET again shows high FDG signal (Fig. 3d). For comparison, Fig. 3a,b shows that there is no significant tophus on the right foot. There are several surprising discoveries in this study. The first is that DECT shows a huge tophus attached superiorly to the left patella, the size of the tophus exceeding that of the patella. This is completely unsuspected by physical examination and plain radiograph alone. The extent of this tophus extends beyond the MRI field. This is because conventional MRI covers only the areas of the knee joint which are required in assessment of other knee pathologies. Hence, our MRI is able to visualize only the inferior half of this particular tophus. Our MRI does show that this supra-patella mass has intensity in T1 and T2 sequences compatible with those of urate tophi. Although less spectacular, the images around the left big toe also confirm that physical examination and plain radiography have greatly under-assessed the size of the tophus at that location. The second interesting finding in this study is that when we compare DECT to MRI, we notice that DECT does not necessarily provide all the information about the sizes of the tophi. MRI of the left knee reveals a large tophus situated in a posterior location. However, DECT in the same location reveals only mildly scattered urate compounds. Apparently, this tophus consists of more cellular or fibrous structures than urate crystals. The third and final contribution in this paper is that, similar to two other papers, PET does show that gout tophi reveal significant inflammation. This is compatible with the histology of recently reported tophi.7 How inflammation prevents the crystals from being solubilized remains an enigma. Since urate solubility is highly dependent on the pH of the environment, perhaps the inflammation and associated fibrosis creates a pH of the surrounding tissues high enough to protect the crystals from being rapidly dissolved. New techniques of visualizing pH in vivo would be a useful direction in future research.8

Tophus resolution with pegloticase: a prospective dual-energy CT study

Comparison of dual-energy CT, ultrasound and surface measurement for assessing tophus dissolution during rapid urate debulking

Dual-energy CT assessment of rapid monosodium urate depletion and bone erosion remodelling during pegloticase plus methotrexate co-therapy

Examination of monosodium urate crystal depletion and bone erosion remodeling during pegloticase treatment in patients with uncontrolled gout: exploratory dual-energy computed tomography findings from MIRROR RCT

Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation

“High Score” in a Patient with Tophaceous Gout

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout

Tophaceous Gout in an Anorectic Patient Visualized by Dual Energy Computed Tomography (DECT)

Comparing the Usefulness of Four Imaging Techniques in the Same Gouty Arthritis Patient

Two-year reduction of dual-energy CT urate depositions during a treat-to-target strategy in gout in the NOR-Gout longitudinal study

Musculoskeletal Ultrasound in Monitoring the Efficacy of Gout: A Prospective Study Based on Tophus and Double Contour Sign

High-resolution ultrasound evaluation in the follow-up of treat to target urate-lowering therapy in gout: an observational study

Assessing tophaceous spinal gout treatment response using dual-energy CT as a point-of-care imaging modality: case report

Calcium Pyrophosphate Dihydrate Crystal Deposition in Gouty Tophi

Are gout patients with negative dual-energy computed tomography for monosodium urate crystal deposition easy to treat?

CHANGE OF ULTRASONOGRAPHIC SIGNS DURING URATE LOWERING THERAPY IN PATIENTS WITH GOUT

Dual energy CT in gout: a prospective validation study

Detection of uric acid depositing in tophaceous gout using a new dual energy spectral CT technology.

Intensive urate-lowering with pegloticase plus methotrexate co-therapy in uncontrolled gout patients with and without chronic kidney disease: A retrospective case series

The Gouty Tophus: a Review